0001179110-19-011180.txt : 20191023 0001179110-19-011180.hdr.sgml : 20191023 20191023121553 ACCESSION NUMBER: 0001179110-19-011180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191021 FILED AS OF DATE: 20191023 DATE AS OF CHANGE: 20191023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOTT DARCY G CENTRAL INDEX KEY: 0001179972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 191163270 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY, INC. CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEQUITY INC DATE OF NAME CHANGE: 20080227 4 1 edgar.xml FORM 4 - X0306 4 2019-10-21 0 0001428336 HEALTHEQUITY, INC. HQY 0001179972 MOTT DARCY G C/O HEALTHEQUITY, INC. 15 W. SCENIC POINTE DR., STE. 100 DRAPER UT 84020 0 1 0 0 Executive VP and CFO Common Stock 2019-10-21 4 S 0 4000 56.8967 D 42000 D Stock Option (right to buy) 41.28 2027-03-27 Common Stock 19897 19897 D Stock Option (right to buy) 25.39 2025-03-26 Common Stock 25000 25000 D Stock Option (right to buy) 14 2024-07-30 Common Stock 100000 100000 D Stock Option (right to buy) 61.72 2028-03-27 Common Stock 14228 14228 D Stock Option (right to buy) 73.61 2029-03-26 Common Stock 15337 15337 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.86 to $56.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4. The option is exercisable as to 9,948 shares. The option vests as to 4,974 shares on March 27, 2020 and one installment of 4,975 shares on March 27, 2021. The option is immediately exercisable. The option is exercisable as to 3,557 shares. The remaining options vest in three equal installments of 3,557 shares on March 27, 2020, 2021, and 2022. The option vests as to 3,835 shares on March 27, 2020. The remaining options vest as to 3,834 shares on each of March 27, 2021, 2022 and 2023. /s/ Darcy G. Mott 2019-10-23